Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria (Q33976467)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049277%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049277%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

main subject

Gram-negative bacteria

0 references

pneumonia

0 references

author name string

A D Kashuba

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049277%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A N Nafziger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049277%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

G L Drusano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049277%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J S Bertino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049277%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049277%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049277%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049277%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049277%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

623-629

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049277%20AND%20SRC:MED&resulttype=core&format=json

Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms

11 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

Risk factors for the development of auditory toxicity in patients receiving aminoglycosides.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

Risk Factors for Nephrotoxicity in Patients Treated with Aminoglycosides

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

Gentamicin pharmacokinetics in patients with malignancies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

Preventing nosocomial pneumonia: state of the art and perspectives for the 1990s

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

Mathematical Examination of Dual Individualization Principles (I): Relationships between AUC above MIC and Area under the Inhibitory Curve for Cefmenoxime, Ciprofloxacin, and Tobramycin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

Aminoglycosides versus beta-lactams in gram-negative pneumonia.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

Prediction of creatinine clearance from serum creatinine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

Evaluation of nephrotoxic and ototoxic effects of tobramycin in worldwide study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoxime.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89170

Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

29 October 2018

1 reference

12 December 2020

A model for predicting nephrotoxicity in patients treated with aminoglycosides

1 reference

12 December 2020

Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosides

1 reference

12 December 2020

Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques

1 reference

12 December 2020

Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995

1 reference

12 December 2020

Pseudomonas Bacteremia: Pharmacologic and Other Bases for Failure of Treatment with Gentamicin

1 reference

12 December 2020

Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections

1 reference

12 December 2020

Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis

1 reference

12 December 2020

Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients

1 reference

12 December 2020

Adverse effects of nosocomial infection

1 reference

12 December 2020

Deaths from nosocomial infections: experience in a university hospital and a community hospital

1 reference

12 December 2020

Increased burn patient survival with individualized dosages of gentamicin

1 reference

12 December 2020

Nosocomial infections and hospital deaths. A case-control study

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.43.3.623

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049277%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049277%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference